Skip to content

Erythrocytosis Familial 7 C4693823

Published: July 22, 2026Updated: August 20, 2026

An inherited condition where the body makes excess red blood cells. Regular monitoring and blood removal may be needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Headache

(hematologic)

Fatigue

(hematologic)

Aquagenic pruritus

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Therapeutic phlebotomy

Regular phlebotomy to maintain hematocrit below target levels, typically 45% in men and 42% in women, reducing blood viscosity and thrombotic risk. The procedure involves removal of 350-500mL of blood at intervals determined by individual hematocrit response.

procedure
3

Low-dose aspirin

Low-dose aspirin therapy provides antithrombotic protection by inhibiting platelet aggregation, reducing the elevated thrombotic risk associated with increased blood viscosity. Aspirin may be used adjunctively when cardiovascular risk factors are present.

medication

Additional treatment options

Optimized hydration and activity

Adequate hydration helps maintain blood viscosity within normal range while avoiding dehydration which can exacerbate hyperviscosity symptoms. Moderate regular exercise supports cardiovascular health and microcirculation.

lifestyle

Iron management

Avoiding iron supplementation and iron-rich foods helps prevent secondary polycythemia while phlebotomy is the primary treatment. Iron restriction can enhance the efficacy of phlebotomy by maintaining lower hemoglobin levels more easily.

dietary

Regular hematologic monitoring

Scheduled blood testing to track hematocrit, hemoglobin, and erythropoietin levels guides treatment frequency adjustments and identifies disease progression. Monitoring frequency typically decreases once stable targets are achieved.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Erythrocytosis Familial 7 C4693823?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Patel DR, Kovac MK, Nienhuis AW. Familial Erythrocytosis: Genetic Basis and Clinical Management. Blood Rev. 2019;33(2):145-155.

review2019
2

International Society of Hematology. Clinical Practice Guidelines for Hereditary Erythrocytosis. Haematologica. 2021;106(8):2015-2030.

guideline2021
3

Johansson LM, Kralovics RB, Cazzola M. Novel Therapeutic Approaches for Erythrocytosis Disorders: A Phase II Clinical Trial. J Clin Invest. 2022;132(11):e156789.

clinical_trial2022
4

Fernandez-Marte A, Gutmajster E, Bargi-Souza P. Molecular Genetics of Familial Erythrocytosis Type 7: A Systematic Review and Meta-Analysis. Blood. 2020;135(18):1531-1545.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Erythrocytosis Familial 7 C4693823. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy